Sandoz Articles
NEGATIVE VIEWS ON GLAXO
27 June 1994
MERCK/SANDOZ VIE FOR MARKET SHARE
27 June 1994
GENETIC THERAPY IN LINK-UP WITH SANDOZ
27 June 1994
SANDIMMUN SET FOR DECLINE, SAYS ANALYST
27 June 1994
FRANCE BARS IMIGRAN REIMBURSEMENT?
27 June 1994
EUROPEAN STOCK COMMENT
20 June 1994
OCTREOSCAN APPROVED IN USA
13 June 1994
EUROPEAN STOCK COMMENT
6 June 1994
SANDOZ AGREEMENT WITH GERBER
30 May 1994
BOEH INGELHEIM LAUNCHES ANDANTE
30 May 1994
EARNINGS UP AT SANKYO
30 May 1994
EUROPEAN STOCK COMMENT
30 May 1994
REVISED SANDOZ/SCRIPPS DEAL
23 May 1994
SHAREHOLDERS AGREE SANDOZ PLANS
16 May 1994
LABORATOIRES MONAL APPOINTMENTS
2 May 1994
RESTRUCTURING PHARMA MARKETING IN JAPAN
2 May 1994
EUROPEAN STOCK COMMENT
25 April 1994
SLOW QTR AT SANDOZ AS PHARMA SALES DECLINE
25 April 1994
STRONG SWISS FRANCS HITS CIBA'S 1st QTR
25 April 1994
SANDOZ APPOINTMENT
18 April 1994
GPIA APPOINTMENT AND MEMBERS
11 April 1994
ACTISITE CLEARED FOR MARKET IN USA
11 April 1994
INDUSTRY WARNED OVER DECLINE OF DOCTOR ROLE
11 April 1994
JAPANESE COs TOO DEPENDENT ON HOME MKT
11 April 1994
NEW THERAPIES FOR MULTIPLE SCLEROSIS
4 April 1994
NEW YORK STOCK COMMENT
4 April 1994
TOKYO STOCK COMMENT
4 April 1994
SANDIMMUN NEORAL WELCOMED AS ADVANCE
4 April 1994
MERCK & CO FIGHTS BACK OVER LESCOL
4 April 1994
NET PROFITS UP 14% AT SANDOZ IN 1993
4 April 1994
TOKYO STOCK COMMENT
28 March 1994
SANOFI WINTHROP APPOINTMENT
28 March 1994
PRICE WAR LOOMING FOR HYPOLIPEMICS
28 March 1994
ELF SANOFI CONTINUING TO BUILD IN EASTERN EUROPE
28 March 1994
JAPANESE DRUG APPROVALS
21 March 1994
CANADA OTC COUGH/ COLD SALES BOOM
21 March 1994
GEMA SA OF SPAIN RENAMED BIOCHEMIE
14 March 1994
EUROPEAN STOCK COMMENT
7 March 1994
SANDOZ AND MMD IN COPROMOTION
28 February 1994
N AMERICAN PHARMA MARKET STUDIED
28 February 1994
SWEDISH PHARMA MARKET GROWTH SLOWDOWN
28 February 1994
EUROPEAN STOCK COMMENT
21 February 1994
MIGRAINE MARKET SET TO BLOSSOM
21 February 1994
JOB CUTS AT SANDOZ
14 February 1994
INTERNEURON LIVING OFF THE FAT OF THE LAND
14 February 1994
UK PRODUCT NEWS IN BRIEF
7 February 1994
EUROPEAN PHARMA MARKET study
7 February 1994
EUROPEAN STOCK COMMENT
31 January 1994
SANDOZ APPOINTMENT
31 January 1994
SANKYO, NBI IN CROSS LICENSING DEAL
31 January 1994
ROUND-UP OF 1993'S NEW CHEMICAL ENTITIES
31 January 1994
PHARMA SALES DRIVE SANDOZ IN 1993
31 January 1994
WINNERS AND LOSERS IN GLOBAL PHARMA INDUSTRY
31 January 1994
UPDATE ON INTERNATIONAL PHARMA WHOLESALING By Mick Maroney
31 January 1994
PHARMACEUTICAL TRENDS AND PROSPECTS
24 January 1994
SANDOZ APPOINTMENT
24 January 1994
SANDOZ IN DEAL WITH AJINOMOTO
24 January 1994
SANDOZ READY TO ACQUIRE MONAL?
24 January 1994
WORLD HEMATOLOGY MARKET FORECASTS
24 January 1994
SANDOZ RECEIVES APPROVAL
17 January 1994
LIKELY IMPACT ON DRUG FIRMS OF ITALIAN REFORMS
17 January 1994
FDA YEAR-END APPROVALS FOR 1993
10 January 1994
TOKYO STOCK COMMENT
10 January 1994
DRUGMAKERS IN ITALY PANIC ON NEW SALES FEARS
10 January 1994
1992 SEES SMALLER COMPANY MERGERS
10 January 1994
SANKYO-DEVELOPED DRUGS SPUR GROWTH
10 January 1994
NIZORAL TOPS SKIN DRUG LEAGUE IN 1992
10 January 1994
SANDOZ READY TO TRY GENERICS, OTC MARKET
10 January 1994
EUROPEAN STOCK COMMENT
20 December 1993
SANDOZ UNVEILS IL-6 TRIAL DATA
20 December 1993
BAD NEW FOR MEDIMMUNE AS RESPIGAM STUMBLES
13 December 1993
ANALYSTS FORECAST FDA YEAR-END APPROVALS
13 December 1993
US NIH FORUM ON COLLABORATIVE R&D
13 December 1993
STRATEGIC ALLIANCE FOR B-MANNHEIM/CELLPRO
13 December 1993
SANDOZ AGREEMENT WITH TERRY FOX LABS
6 December 1993
SANDIMMUN RECEIVES ADDITIONAL INDICATION
6 December 1993
FDA PANEL BACKS FUJISAWA'S PROGRAF
6 December 1993
DRUGS FOR CANCER IMMUNOLOGY IN 1992
29 November 1993
PROGRAF TRIALS BEGIN IN UK
29 November 1993
STUDY SHOWS PATIENTS PREFER GRANISETRON
22 November 1993
STUDY SAYS CLOZARIL USE SAVES MONEY
15 November 1993
SANDOZ/GAZZONI DEAL FLOUNDERS
15 November 1993
ASTRA'S ROXIAM HITS TOXICITY TROUBLE
8 November 1993
SANDOZ PURCHASE
1 November 1993
MARKET WARMS TO COUGH & COLD SEASON IN USA
1 November 1993
AFFYMAX EXPANDS DRUG SCREENING CAPACITY
1 November 1993
KNIGHTS OF THE "ROUND TABLE" STUDY EC POLICY
25 October 1993
EUROPEAN STOCK COMMENT
25 October 1993
SALES UP IN 1st NINE MTHS AT SANDOZ
25 October 1993
HOECHST-ROUSSEL TO FIGHT COGNEX PATENT
11 October 1993
SANDOZ OPENS CENTER IN JAPAN
4 October 1993
BROMOCRIPTINE SUSPENSION IN USA?
4 October 1993
NEW DATA ON SANDOZ' LAMISIL VS SPORANOX
4 October 1993
REFORMULATION OF CICLOSPORIN A
4 October 1993
NEW CANCER THERAPIES MOVE INTO THE CLINIC
4 October 1993
PMA WARNING ON FUTURE OF BIOTECHNOLOGY
27 September 1993
SANDOZ LAUNCHES LAMISIL IN JAPAN
27 September 1993
SANDOZ R&D DEAL WITH PROCEPT
20 September 1993
NEW TRIAL RESULTS REPORTED AT ECCO
20 September 1993
MORE FOREIGN R&D ACTIVITY IN JAPAN
13 September 1993
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
